These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26327786)

  • 1. Pneumocystis Pneumonia in Human Immunodeficiency Virus-infected Adults and Adolescents: Current Concepts and Future Directions.
    Tasaka S
    Clin Med Insights Circ Respir Pulm Med; 2015; 9(Suppl 1):19-28. PubMed ID: 26327786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected adults.
    Tasaka S; Tokuda H
    Expert Opin Med Diagn; 2013 Jan; 7(1):85-97. PubMed ID: 23530845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
    Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
    Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
    J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
    Fisher RG; Nageswaran S; Valentine ME; McKinney RE
    AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
    Kato H; Samukawa S; Takahashi H; Nakajima H
    J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.
    Matsumura Y; Ito Y; Yamamoto M; Matsushima A; Nagao M; Takakura S; Iinuma Y; Ichiyama S
    J Infect Chemother; 2014 Feb; 20(2):109-14. PubMed ID: 24480550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.
    Hammarström H; Grankvist A; Broman I; Kondori N; Wennerås C; Gisslen M; Friman V
    BMC Infect Dis; 2019 Jul; 19(1):658. PubMed ID: 31337356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice weekly Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia.
    Agrawal AK; Chang PP; Feusner J
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):e1-4. PubMed ID: 21102354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to Trimethoprim-Sulfamethoxazole.
    Lee SM; Cho YK; Sung YM; Chung DH; Jeong SH; Park JW; Lee SP
    Korean J Parasitol; 2015 Jun; 53(3):321-7. PubMed ID: 26174826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in the Diagnosis and Management of
    Tasaka S
    Tuberc Respir Dis (Seoul); 2020 Apr; 83(2):132-140. PubMed ID: 32185915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sulfamethoxazole-trimethoprim-induced pneumonitis in a patient with hemophilia B who was infected with the human immunodeficiency virus].
    Yamagishi T; Yoshida S; Fukutake K; Utsumi K; Ichinose Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):822-8. PubMed ID: 8810766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies.
    Tasaka S; Tokuda H
    Kansenshogaku Zasshi; 2014 Nov; 88(6 Suppl 11):26-39. PubMed ID: 25796923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii Pneumonia in a Patient with Breast Cancer Receiving Neoadjuvant Dose-dense Chemotherapy.
    Watanabe H; Kitahara Y; Murakami Y; Nihashi F; Matsushima S; Eifuku T; Uto T; Sato J; Imokawa S; Suda T
    Intern Med; 2020 Apr; 59(7):987-990. PubMed ID: 31839658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies.
    Tasaka S; Tokuda H
    J Infect Chemother; 2012 Dec; 18(6):793-806. PubMed ID: 22864454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Warren E; George S; You J; Kazanjian P
    Pharmacotherapy; 1997; 17(5):900-16. PubMed ID: 9324180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
    Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
    BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis carinii pneumonia prophylaxis and early clinical manifestations of severe perinatal human immunodeficiency virus type 1 infection. Northern California Pediatric HIV Consortium.
    Maldonado YA; Araneta RG; Hersh AL
    Pediatr Infect Dis J; 1998 May; 17(5):398-402. PubMed ID: 9613653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.